ABCC9 Gene Cardiomyopathy dilated type 1O Genetic Test
Components
- Test Name: ABCC9 Gene Cardiomyopathy dilated type 1O Genetic Test
- Price: 4400.0 AED
- Sample Condition: Blood
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test type: Cardiovascular Pneumology Disorders
- Doctor: Cardiologist
- Test Department: Genetics
Pre Test Information
Clinical History of Patient who is going for ABCC9 Gene Cardiomyopathy, dilated type 1O NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with ABCC9 Gene Cardiomyopathy, dilated type 1O NGS Genetic DNA Test gene ABCC9.
Test Details
ABCC9 gene cardiomyopathy, dilated type 1O is a genetic disorder that affects the heart muscle, leading to a condition called dilated cardiomyopathy. This disorder is caused by mutations in the ABCC9 gene.
To diagnose ABCC9 gene cardiomyopathy, dilated type 1O, a Next-Generation Sequencing (NGS) genetic test can be performed. NGS is a high-throughput sequencing technology that allows for the simultaneous analysis of multiple genes in a single test.
The NGS genetic test for ABCC9 gene cardiomyopathy, dilated type 1O involves obtaining a DNA sample from the patient, usually through a blood or saliva sample. The DNA is then sequenced using NGS technology to identify any mutations or variations in the ABCC9 gene.
The results of the NGS genetic test can help confirm a diagnosis of ABCC9 gene cardiomyopathy, dilated type 1O and provide information about the specific mutation present in the ABCC9 gene. This information can be useful for guiding treatment decisions and providing genetic counseling to affected individuals and their families.
It is important to note that genetic testing for ABCC9 gene cardiomyopathy, dilated type 1O is typically performed by a healthcare professional with expertise in genetics. They can interpret the test results and provide appropriate recommendations and support.
| Test Name | ABCC9 Gene Cardiomyopathy dilated type 1O Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Cardiovascular Pneumology Disorders |
| Doctor | Cardiologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for ABCC9 Gene Cardiomyopathy, dilated type 1O NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with ABCC9 Gene Cardiomyopathy, dilated type 1O NGS Genetic DNA Test gene ABCC9 |
| Test Details |
ABCC9 gene cardiomyopathy, dilated type 1O is a genetic disorder that affects the heart muscle, leading to a condition called dilated cardiomyopathy. This disorder is caused by mutations in the ABCC9 gene. To diagnose ABCC9 gene cardiomyopathy, dilated type 1O, a Next-Generation Sequencing (NGS) genetic test can be performed. NGS is a high-throughput sequencing technology that allows for the simultaneous analysis of multiple genes in a single test. The NGS genetic test for ABCC9 gene cardiomyopathy, dilated type 1O involves obtaining a DNA sample from the patient, usually through a blood or saliva sample. The DNA is then sequenced using NGS technology to identify any mutations or variations in the ABCC9 gene. The results of the NGS genetic test can help confirm a diagnosis of ABCC9 gene cardiomyopathy, dilated type 1O and provide information about the specific mutation present in the ABCC9 gene. This information can be useful for guiding treatment decisions and providing genetic counseling to affected individuals and their families. It is important to note that genetic testing for ABCC9 gene cardiomyopathy, dilated type 1O is typically performed by a healthcare professional with expertise in genetics. They can interpret the test results and provide appropriate recommendations and support. |
